trial
as of 2026-07-01Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
NCTId NCT00423878
at a glance
Phase 4 · Completed
Enrollment 215 (actual)
Sponsored by National Institute of Mental Health (NIMH)
Primary completion 2009-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
215 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2007-01
Primary completion
2009-10
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
National Institute of Mental Health (NIMH)Lead Sponsor
Investigators
2
T. Scott Stroup, MD, MPHPrincipal Investigator
Joseph P. McEvoy, MDStudy Director
Sites
28 total
Colton, United StatesPalo Alto, United StatesNew Haven, United StatesBoca Raton, United StatesMiami, United StatesAtlanta, United StatesAugusta, United StatesIowa City, United StatesWichita, United StatesShreveport, United StatesGlen Burnie, United StatesBoston, United States
Facts & assertions
4 sourced
Enrollment
215
Phase
PHASE4
Primary Completion Date
2009-10
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person
person